Back to results
US 6,783,935 B2Granted
Genetic polymorphism of MxA protein and use thereof
AssigneeKabushiki Kaisha Toshiba
InventorsMinako Hijikata, Shunji Mishiro, Yasuhiko Oota, Koji Hashimoto
Life of this patent
Estimating the term…
Abstract
The present invention provides polynucleotides having base sequences of sequence Nos. 1 to 4, as polynucleotides having polymorphism sites capable of being useful indicators for prediction of validity of interferon therapy.
Claims9
A polynucleotide comprising the polynucleotide of SEQ ID NO:1 (at), or
- comprising the complementary strand of the polynucleotide of SEQ ID NO:1.
Dependencies are inferred from the claim text.